Doctor profile · Federal record
Dr. Hemang Dave, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Marmora, NJ
- NPI 1891782371
- Accepts Medicare
- MIPS 89.4 / 100 · 2023
- 44 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
210 S Shore RD, Suite 106
Marmora, NJ 082231200
(609) 390-7888
fax (609) 390-2614
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- March 10, 2011
- Year of graduation
- 1982 — 44 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- New Jersey #MA059378
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1891782371. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
63,227
Distinct HCPCS
10
Medicare allowed
$1,143,705
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1442 |
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 16,860 | 14 | $1 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 7,500 | 37 | $8 | |
J9271 |
Injection, pembrolizumab, 1 mg | 6,800 | 12 | $54 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 6,680 | 39 | $7 | |
J0897 |
Injection, denosumab, 1 mg | 6,120 | 48 | $23 | |
J1756 |
Injection, iron sucrose, 1 mg | 4,800 | 11 | $0 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 4,100 | 24 | $21 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,820 | 12 | $45 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,312 | 502 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,291 | 47 | $0 |
In context: peer comparison
Among 3 peers in Marmora Hematology & Oncology Physician, average services per provider: 2,255. This provider delivers 28× the peer median.Open Payments
Industry payments received
All-time total
$2,507
Transactions
81
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Pfizer INC. | 16 | $301.84 | |
| Janssen Biotech, INC. | 8 | $221.71 | |
| Novartis Pharmaceuticals Corporation | 7 | $157.74 | |
| Astellas Pharma US INC | 4 | $146.83 | |
| Seapearl East, INC | 1 | $126.27 | |
| Emd Serono, INC. | 5 | $109.11 | |
| Celgene Corporation | 6 | $100.56 | |
| AstraZeneca Pharmaceuticals Lp | 6 | $93.17 | |
| Merck Sharp & Dohme LLC | 5 | $89.27 | |
| Gilead Sciences, INC. | 5 | $86.42 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $84.96 | |
| Daiichi Sankyo INC. | 3 | $73.78 | |
| Eisai INC. | 4 | $71.10 | |
| Acrotech Biopharma INC. | 3 | $62.88 | |
| Bayer Healthcare Pharmaceuticals INC. | 3 | $58.12 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
482
Patients
72
Total drug cost
$558,320
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 77 | 21 | $96,628 |
| Warfarin Sodium | Generic | 75 | 17 | $1,368 |
| Letrozole | Generic | 41 | 11 | $2,081 |
| Exemestane | Generic | 39 | 0 | $6,041 |
| Imbruvica (Ibrutinib) | Brand | 37 | 0 | $413,490 |
| Tamoxifen Citrate | Generic | 34 | 12 | $1,470 |
| Hydroxyurea | Generic | 30 | 0 | $2,366 |
| Xarelto (Rivaroxaban) | Brand | 25 | 0 | $29,585 |
| Prednisone | Generic | 24 | 0 | $365 |
| Raloxifene Hcl | Generic | 23 | 0 | $2,633 |
Hospital affiliations
Frequently asked questions
What is Dr. Hemang Dave's medical specialty?
Dr. Hemang Dave practices Hematology & Oncology Physician in Marmora, NJ.
Where does Dr. Hemang Dave practice?
Dr. Hemang Dave practices at 210 S Shore RD, Marmora, NJ 082231200. Office phone: 6093907888.
What is Dr. Hemang Dave's NPI?
Dr. Hemang Dave's National Provider Identifier (NPI) is 1891782371, issued by NPPES.
Does Dr. Hemang Dave accept Medicare assignment?
Yes. Dr. Hemang Dave accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Hemang Dave commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS J1442); Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS Q5106); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.